Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse eventsWeihong Zhang, Xiubao Ren, Yanjuan Xiong et al.|Cancer Biology and Medicine|2021Cited by 9
Conversion surgery for tislelizumab combined chemotherapy for T4a/N3 esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study.Chen Zhang, Hongjing Jiang, Xiaobin Shang et al.|Journal of Clinical Oncology|2024Cited by 0
Autologous Cytokine-induced Killer Cell Combination Therapy Enhances Response to Immune Checkpoint Inhibitors in Patients with Refractory Clear Cell Renal Cell CarcinomaShuzhan Li, Xiubao Ren, Jing Qin et al.|Research Square|2025Cited by 0
Camrelizumab with or without Autologous Cytokine-induced Killer Cell Therapy in Patients with Refractory Clear Cell Renal Cell Carcinoma: A Randomized Pilot StudyShuzhan Li, Xiubao Ren, Jing Qin et al.|Research Square|2025Cited by 0